Blog

Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman

Photos taken from Cathy Eng/X

May 20, 2024, 13:23

Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman

Cathy Eng shared on X:

“Last debate Great Debates & Updates on Day 1 w Dr. Neil Segal, Memorial Sloan Kettering Cancer and Dr. Michael Overman, Memorial Sloan Kettering Cancer: Is there a role for IO therapy in MSS (pMMR) patients? Yes or no? More GREAT speakers tomorrow on Day 2. Yelena Y. Janjigian.”

Source: Cathy Eng/X

Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.

cancer Cancer Conference Cancer Management Cathy Eng Day 1 Great Debates immunotherapy IO therapy Memorial Sloan Kettering Michael Overman MSS patients Neil Segal OncoDaily Oncology oncology debate oncology speakers pMMR patients Yelena Y. Janjigian

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage